NO323231B1 - Soyaekstrakt, fremgangsmate for fremstilling derav og farmasoytisk blanding. - Google Patents
Soyaekstrakt, fremgangsmate for fremstilling derav og farmasoytisk blanding. Download PDFInfo
- Publication number
- NO323231B1 NO323231B1 NO20000399A NO20000399A NO323231B1 NO 323231 B1 NO323231 B1 NO 323231B1 NO 20000399 A NO20000399 A NO 20000399A NO 20000399 A NO20000399 A NO 20000399A NO 323231 B1 NO323231 B1 NO 323231B1
- Authority
- NO
- Norway
- Prior art keywords
- extract
- weight
- water
- treatment
- soy
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- 230000008569 process Effects 0.000 title claims abstract description 7
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title description 10
- 235000020712 soy bean extract Nutrition 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 95
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 57
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 57
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 40
- -1 glucoside isoflavones Chemical class 0.000 claims abstract description 29
- 238000011282 treatment Methods 0.000 claims abstract description 27
- 229930182478 glucoside Natural products 0.000 claims abstract description 21
- 244000068988 Glycine max Species 0.000 claims abstract description 17
- 206010027304 Menopausal symptoms Diseases 0.000 claims abstract description 14
- 208000007848 Alcoholism Diseases 0.000 claims abstract description 13
- 201000007930 alcohol dependence Diseases 0.000 claims abstract description 10
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 8
- 201000011510 cancer Diseases 0.000 claims abstract description 6
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims abstract description 5
- 206010006187 Breast cancer Diseases 0.000 claims abstract description 4
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 4
- 206010060862 Prostate cancer Diseases 0.000 claims abstract description 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 78
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 25
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 24
- 229930188627 soysaponin Natural products 0.000 claims description 24
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 13
- 238000000605 extraction Methods 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 11
- 239000013543 active substance Substances 0.000 claims description 10
- 230000002265 prevention Effects 0.000 claims description 10
- 239000012074 organic phase Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 7
- 239000011347 resin Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 238000001179 sorption measurement Methods 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 5
- 238000012986 modification Methods 0.000 claims description 5
- 239000000010 aprotic solvent Substances 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 238000011010 flushing procedure Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 235000019764 Soybean Meal Nutrition 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 238000010828 elution Methods 0.000 claims description 2
- 239000004455 soybean meal Substances 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 235000013312 flour Nutrition 0.000 abstract description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 2
- 229930187719 Soyasaponin Natural products 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 235000012424 soybean oil Nutrition 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 54
- 229930182490 saponin Natural products 0.000 description 21
- 150000007949 saponins Chemical class 0.000 description 21
- 235000017709 saponins Nutrition 0.000 description 21
- 230000000694 effects Effects 0.000 description 14
- 102000009151 Luteinizing Hormone Human genes 0.000 description 10
- 108010073521 Luteinizing Hormone Proteins 0.000 description 10
- 229940040129 luteinizing hormone Drugs 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 241000700159 Rattus Species 0.000 description 9
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000001028 anti-proliverative effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 206010060800 Hot flush Diseases 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000007240 daidzein Nutrition 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000009245 menopause Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 206010010219 Compulsions Diseases 0.000 description 2
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 2
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 2
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 2
- 208000033830 Hot Flashes Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FEFAIBOZOKSLJR-UHFFFAOYSA-N Miltirone Chemical compound C1CCC(C)(C)C=2C1=C1C(=O)C(=O)C(C(C)C)=CC1=CC=2 FEFAIBOZOKSLJR-UHFFFAOYSA-N 0.000 description 2
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 206010001584 alcohol abuse Diseases 0.000 description 2
- 208000025746 alcohol use disease Diseases 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- AUZONCFQVSMFAP-UHFFFAOYSA-N disulfiram Chemical compound CCN(CC)C(=S)SSC(=S)N(CC)CC AUZONCFQVSMFAP-UHFFFAOYSA-N 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 2
- 235000006539 genistein Nutrition 0.000 description 2
- 229940045109 genistein Drugs 0.000 description 2
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 2
- 235000008466 glycitein Nutrition 0.000 description 2
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 2
- OZBAVEKZGSOMOJ-MIUGBVLSSA-N glycitin Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OZBAVEKZGSOMOJ-MIUGBVLSSA-N 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000008389 polyethoxylated castor oil Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000002747 voluntary effect Effects 0.000 description 2
- HMJIYCCIJYRONP-UHFFFAOYSA-N (+-)-Isradipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC2=NON=C12 HMJIYCCIJYRONP-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
- 229940084657 Benzodiazepine receptor inverse agonist Drugs 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- XJTZHGNBKZYODI-UHFFFAOYSA-N Glycitin Natural products OCC1OC(Oc2ccc3OC=C(C(=O)c3c2CO)c4ccc(O)cc4)C(O)C(O)C1O XJTZHGNBKZYODI-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010067572 Oestrogenic effect Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- YTAHJIFKAKIKAV-XNMGPUDCSA-N [(1R)-3-morpholin-4-yl-1-phenylpropyl] N-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamate Chemical compound O=C1[C@H](N=C(C2=C(N1)C=CC=C2)C1=CC=CC=C1)NC(O[C@H](CCN1CCOCC1)C1=CC=CC=C1)=O YTAHJIFKAKIKAV-XNMGPUDCSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000755 benzodiazepine receptor inverse stimulating agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- BTZJQYVYGCCNHY-UHFFFAOYSA-N calcium;urea Chemical compound [Ca].NC(N)=O BTZJQYVYGCCNHY-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007073 chemical hydrolysis Effects 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229960002563 disulfiram Drugs 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229930012930 isoflavone derivative Natural products 0.000 description 1
- 229960004427 isradipine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000035407 negative regulation of cell proliferation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1997132866 DE19732866C2 (de) | 1997-07-30 | 1997-07-30 | Neue Soja-Extrakte, ihre Herstellung, auf ihnen basierende Formulierungen und deren Verwendung für die Prävention oder Behandlung von pre-menopausalen und post-menopausalen Symptomen |
| DE1997132855 DE19732855C2 (de) | 1997-07-30 | 1997-07-30 | Spezieller Soja-Extrakt, dessen Herstellung, diesen enthaltende Formulierungen und deren Verwendung für die Prävention oder Behandlung von Krebs |
| DE1997132822 DE19732822C2 (de) | 1997-07-30 | 1997-07-30 | Soja-Extrakt, dessen Herstellungsverfahren und diesen enthaltende pharmazeutische Zusammensetzungen und deren Verwendung für die Prävention oder Behandlung von Alkoholismus |
| PCT/EP1998/004770 WO1999006057A1 (en) | 1997-07-30 | 1998-07-30 | Soya extract, process for its preparation and pharmaceutical composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20000399D0 NO20000399D0 (no) | 2000-01-26 |
| NO20000399L NO20000399L (no) | 2000-01-26 |
| NO323231B1 true NO323231B1 (no) | 2007-02-05 |
Family
ID=27217588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000399A NO323231B1 (no) | 1997-07-30 | 2000-01-26 | Soyaekstrakt, fremgangsmate for fremstilling derav og farmasoytisk blanding. |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US6280777B1 (zh) |
| EP (1) | EP1001797B9 (zh) |
| JP (2) | JP3570989B2 (zh) |
| KR (1) | KR100388511B1 (zh) |
| CN (1) | CN1089245C (zh) |
| AT (1) | ATE297213T1 (zh) |
| AU (1) | AU740356B2 (zh) |
| CA (1) | CA2298142C (zh) |
| CZ (1) | CZ298532B6 (zh) |
| DE (1) | DE69830495T2 (zh) |
| DK (1) | DK1001797T3 (zh) |
| ES (1) | ES2243005T3 (zh) |
| HK (1) | HK1025507A1 (zh) |
| HU (1) | HU229444B1 (zh) |
| NO (1) | NO323231B1 (zh) |
| PL (1) | PL191191B1 (zh) |
| PT (1) | PT1001797E (zh) |
| RU (1) | RU2183964C2 (zh) |
| SK (1) | SK283491B6 (zh) |
| WO (1) | WO1999006057A1 (zh) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6261565B1 (en) * | 1996-03-13 | 2001-07-17 | Archer Daniels Midland Company | Method of preparing and using isoflavones |
| JP3570989B2 (ja) * | 1997-07-30 | 2004-09-29 | インデナ エッセ ピ ア | 大豆抽出物、その調製方法および医薬組成物 |
| ATE322903T1 (de) | 1999-07-09 | 2006-04-15 | Sun Farm Corp | Diätzusatz zur behandlung von malignitäten und virusinfektionen und verbesserung der immunfunktion |
| JP4413464B2 (ja) * | 1999-12-17 | 2010-02-10 | 光則 小野 | 水溶性の豆ベース抽出物 |
| ES2379055T3 (es) * | 2000-04-18 | 2012-04-20 | Medestea Internazionale S.P.A. | Una composición basada en extractos naturales útiles para la prevención y el tratamiento de las arrugas cutáneas |
| CN1096456C (zh) * | 2000-06-08 | 2002-12-18 | 蒋宇扬 | 连续提取大豆异黄酮、低聚糖、皂甙的工艺 |
| KR20010016220A (ko) * | 2000-11-17 | 2001-03-05 | 이광필 | 대두 배아로부터 생리활성 물질인 이소플라본의 분리정제방법 |
| FR2818096B1 (fr) * | 2000-12-14 | 2004-05-07 | Daniel Chajuss | Composition phytochimique de soja |
| IL148825A0 (en) * | 2002-03-21 | 2002-09-12 | Yeda Res & Dev | Derivatives of isoflavones |
| US20040131749A1 (en) * | 2002-08-29 | 2004-07-08 | Archer-Daniels-Midland Company | Phytochemicals from edible bean process streams |
| ITMI20022723A1 (it) * | 2002-12-20 | 2004-06-21 | Marfarma S R L Ora Marfarma Holding Spa | Composizioni per il trattamento della sindrome post-menopausa. |
| JP4442422B2 (ja) * | 2002-12-24 | 2010-03-31 | 不二製油株式会社 | 高濃度かつ高溶解性のイソフラボン含有組成物及びその製造法 |
| GB0317020D0 (en) * | 2003-07-21 | 2003-08-27 | Sahajanand Biotech Private Ltd | Herbo-mineral formulation for refractory leukemias and lymphomas |
| US7718813B2 (en) | 2003-08-15 | 2010-05-18 | Nature Pure Labs Sw, Inc. | Hydrolysis and purification of active plant compounds suitable for topical application |
| ATE532525T1 (de) | 2003-09-08 | 2011-11-15 | Genyous Biomed Internat Inc | Zusammensetzungen von botanischen extrakten für die krebstherapie |
| RU2006113703A (ru) * | 2003-09-22 | 2007-11-10 | Джиниус Байомед Интернэшнл Инк. (Us) | Композиции hippophae rhamnoides для терапии рака |
| KR100449887B1 (ko) | 2003-10-31 | 2004-09-22 | 주식회사 렉스진바이오텍 | 이소플라본을 함유하는 괴각 추출물의 제조방법 |
| MD2518G2 (ro) * | 2003-12-09 | 2005-06-30 | Элеонора ВАТАМАН | Preparat medicamentos pentru reducerea concentratiei colesterolului in sange |
| JP2005232032A (ja) * | 2004-02-17 | 2005-09-02 | Kikkoman Corp | 敗血症の予防・治療剤 |
| US7658955B2 (en) * | 2004-03-03 | 2010-02-09 | Bio-Botanica, Inc. | Pueraria candollei var. mirifica A Shaw. & Suvat. extract |
| WO2005107780A2 (en) * | 2004-05-10 | 2005-11-17 | Instituto Tecnológico Y De Estudios Superiores De Monterrey (Itesm) | Cancer cell growth inhibition by black bean (phaseolus vulgarisl) extracts |
| AU2005203059B2 (en) * | 2004-07-16 | 2011-11-24 | Johnson & Johnson Consumer Companies, Inc. | Use of legume products for the treatment and prevention of radiotherapy-induced skin damage |
| AU2005229653B2 (en) * | 2004-11-02 | 2006-06-08 | Finocchiaro, Rosario Salvatore Antonio | Wood cutting tool |
| CN100345505C (zh) * | 2004-12-21 | 2007-10-31 | 山东理工大学 | 提取大豆异黄酮、皂甙、低聚糖的挤压加工方法和装置 |
| EP1860956A1 (en) * | 2005-03-09 | 2007-12-05 | Cargill, Incorporated | A method for extracting oilseed and use of the resultant product |
| BRPI0708893A2 (pt) * | 2006-03-15 | 2011-06-28 | Univ Rutgers | composição, processos para aumentar a proporção de pmfs hidroxiladas para pmfs não hidroxiladas em um extrato de planta, e para preparar o extrato de planta, usos de uma pmf hidroxilada, e de uma composição, e, métodos para inibir a proliferação de uma célula cancerosa, para induzir apoptose em uma célula cancerosa, para reduzir a produção de nitrito em um macrófago, e para inibir a ativação de inos e/ou cox-2 em um macrófago |
| US20110117121A1 (en) * | 2006-10-27 | 2011-05-19 | James Dao | Compositions for treatment and inhibition of pain |
| EP2049131A2 (de) * | 2006-11-02 | 2009-04-22 | Dr. Willmar Schwabe GmbH & Co. KG | Verfahren zur herstellung von pflanzenextrakten mit vermindertem gehalt an umweltbedingten unpolaren fremdstoffen |
| BRPI0719164A8 (pt) * | 2006-11-03 | 2017-11-07 | Corn Products Int Inc | Processo para fabricar extratos de soja encapsulados, extrato de soja encapsulado, e, material encapsulado |
| US20110136745A1 (en) * | 2008-01-03 | 2011-06-09 | Monsanto Technology Llc. | Method of selecting soybeans with enhanced bioactivity and compositions for reducing cancer cell viability |
| US8217165B2 (en) * | 2008-06-17 | 2012-07-10 | Pawan Kumar Goel | Process for the extraction of furostanolic saponins from fenugreek seeds |
| CN101477098B (zh) * | 2009-01-08 | 2012-07-18 | 上海交通大学 | 利用大豆天然提取物检测大豆抗蚜性的方法 |
| CN102548565A (zh) * | 2009-10-22 | 2012-07-04 | 株式会社益力多本社 | 癌症发病风险降低剂 |
| CN102977066A (zh) * | 2012-12-07 | 2013-03-20 | 山东大学 | 大豆中异黄酮的提取与纯化方法 |
| CN106028795B (zh) * | 2013-12-13 | 2020-03-03 | 庆尚大学校产学协力团 | 具有高含量异黄酮衍生物的豆叶或豆茎及其制备方法 |
| KR101834764B1 (ko) * | 2014-09-26 | 2018-03-08 | 대한민국 | 유효성분의 함량이 향상된 콩 유래 추출물 |
| KR101834766B1 (ko) * | 2014-09-26 | 2018-03-08 | 대한민국 | 향상된 색택을 가지는 콩 유래 추출물 |
| US10543243B2 (en) | 2016-06-06 | 2020-01-28 | Charsire Biotechnology Corp. | Soybeam seed extract, method for producing the same and uses thereof |
| RU2664148C1 (ru) * | 2017-09-11 | 2018-08-15 | Павел Павлович Хорошутин | Способ производства сухих экстрактов из сырья растительного происхождения |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4501734A (en) * | 1981-03-06 | 1985-02-26 | Wakunaga Yakuhin Kabushiki Kaisha | Promotion of absorption of drugs administered through the alimentary system |
| JPS5933232A (ja) | 1982-08-19 | 1984-02-23 | Tokiwa Kanpou Seiyaku:Kk | マメ科植物からサポニン類およびフラボン類の分離方法 |
| JPS5988064A (ja) | 1982-11-10 | 1984-05-21 | Osaka Chem Lab | 美容食品 |
| JPS59175496A (ja) | 1983-03-23 | 1984-10-04 | Osaka Chem Lab | ソ−ヤサポニンの単離法 |
| JPS6136225A (ja) * | 1984-07-30 | 1986-02-20 | Airin:Kk | サポニン類の単離法 |
| JPS625917A (ja) * | 1985-07-03 | 1987-01-12 | Airin:Kk | 大豆胚芽よりのイソフラボン類を含有しないサポニンの製造法 |
| JPS63245648A (ja) * | 1987-04-01 | 1988-10-12 | Ajinomoto Co Inc | 大豆食品素材の製法 |
| CH679584A5 (zh) * | 1989-11-10 | 1992-03-13 | Nestle Sa | |
| JPH0436242A (ja) * | 1990-05-30 | 1992-02-06 | Fuji Oil Co Ltd | 大豆サポニンの製造法 |
| US5204369A (en) * | 1991-07-01 | 1993-04-20 | The Endowment For Research In Human Biology | Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
| USRE40792E1 (en) * | 1992-05-19 | 2009-06-23 | Novogen Research Pty Ltd | Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| JPH06136225A (ja) | 1992-10-29 | 1994-05-17 | Sanyo Chem Ind Ltd | 水溶性高分子化合物の水分散液 |
| JP3078694B2 (ja) * | 1993-12-17 | 2000-08-21 | キッコーマン株式会社 | ゲニステインの製造法 |
| WO1996010341A1 (en) | 1994-10-03 | 1996-04-11 | Schouten Industries B.V. | Food and health products |
| JPH08291191A (ja) * | 1995-04-24 | 1996-11-05 | Kikkoman Corp | アセチルイソフラボン配糖体の製造法 |
| IT1274481B (it) | 1995-05-12 | 1997-07-17 | Indena Spa | Composizioni farmaceutiche per il trattamento della alcol-dipendenza |
| IT1275436B (it) | 1995-05-19 | 1997-08-07 | Indena Spa | Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza |
| US6020471A (en) * | 1996-09-13 | 2000-02-01 | Abbott Laboratories | Process for isolating phytoestrogens from plant protein |
| JP3570989B2 (ja) * | 1997-07-30 | 2004-09-29 | インデナ エッセ ピ ア | 大豆抽出物、その調製方法および医薬組成物 |
-
1998
- 1998-07-30 JP JP2000504870A patent/JP3570989B2/ja not_active Expired - Fee Related
- 1998-07-30 ES ES98942659T patent/ES2243005T3/es not_active Expired - Lifetime
- 1998-07-30 CN CN98807664A patent/CN1089245C/zh not_active Expired - Fee Related
- 1998-07-30 CZ CZ20000223A patent/CZ298532B6/cs not_active IP Right Cessation
- 1998-07-30 CA CA002298142A patent/CA2298142C/en not_active Expired - Fee Related
- 1998-07-30 DK DK98942659T patent/DK1001797T3/da active
- 1998-07-30 DE DE69830495T patent/DE69830495T2/de not_active Expired - Lifetime
- 1998-07-30 AT AT98942659T patent/ATE297213T1/de active
- 1998-07-30 EP EP98942659A patent/EP1001797B9/en not_active Expired - Lifetime
- 1998-07-30 WO PCT/EP1998/004770 patent/WO1999006057A1/en active IP Right Grant
- 1998-07-30 KR KR10-2000-7001016A patent/KR100388511B1/ko not_active IP Right Cessation
- 1998-07-30 AU AU90711/98A patent/AU740356B2/en not_active Ceased
- 1998-07-30 RU RU2000105259/14A patent/RU2183964C2/ru not_active IP Right Cessation
- 1998-07-30 PL PL337520A patent/PL191191B1/pl unknown
- 1998-07-30 PT PT98942659T patent/PT1001797E/pt unknown
- 1998-07-30 HU HU0003058A patent/HU229444B1/hu not_active IP Right Cessation
- 1998-07-30 SK SK104-2000A patent/SK283491B6/sk not_active IP Right Cessation
-
2000
- 2000-01-26 NO NO20000399A patent/NO323231B1/no not_active IP Right Cessation
- 2000-01-28 US US09/492,921 patent/US6280777B1/en not_active Expired - Lifetime
- 2000-07-04 HK HK00104037A patent/HK1025507A1/xx not_active IP Right Cessation
-
2001
- 2001-07-11 US US09/902,226 patent/US6607757B2/en not_active Expired - Lifetime
-
2002
- 2002-04-23 JP JP2002120590A patent/JP2003002838A/ja active Pending
-
2003
- 2003-06-30 US US10/608,213 patent/US7108871B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO323231B1 (no) | Soyaekstrakt, fremgangsmate for fremstilling derav og farmasoytisk blanding. | |
| US6017893A (en) | Use of isoflavones to prevent hair loss and preserve the integrity of existing hair | |
| US6399579B1 (en) | Compositions comprising icariside I and anhydroicaritin and methods for making the same | |
| JP2004002304A (ja) | フィト−エストロゲン、類似体の健康補助剤製造のための使用方法 | |
| NO318696B1 (no) | Ernærings- eller mattilskuddsblanding samt anvendelse derav, for fremstilling av doseringsform. | |
| KR100934022B1 (ko) | 에스트로겐 활성이 우수한 보골지 추출물 또는 상기 보골지추출물로부터 분리한 활성성분을 포함하는 조성물 | |
| KR100348147B1 (ko) | 골다공증 예방 및 치료에 효과를 갖는 갈근 추출물 | |
| Ammar et al. | Phytochemical and biological studies of butea frondosa Roxb. leaves growing in Egypt | |
| KR102077612B1 (ko) | 에스트로겐 활성 및 유방암 억제 효능을 지닌 복분자 추출물 및 sanguiin H-6 그리고 이의 제조방법 | |
| KR20190113127A (ko) | 레드클로버 추출물을 함유하는 여성갱년기 개선용 조성물 | |
| Pullaiah | Forskolin | |
| CN112168892B (zh) | 一种用于改善围绝经期妇女综合征症的中药组合物 | |
| CN112168893B (zh) | 一种中药组合物用于改善围绝经期妇女综合征症的用途 | |
| Udgata et al. | Soybean isoflavones: Remedial nutraceuticals in Indian perspective | |
| Al–Zubaide et al. | EFFECT OF METHANOL EXTRACT OF ALTHAEA OFFICINALIS L. FLOWERS ON ESTROGEN AND OVARY OF RATS | |
| KR100348148B1 (ko) | 골다공증 예방 및 치료에 효과를 갖는 갈근 추출물 | |
| AU777561B2 (en) | Health supplements containing phyto-oestrogen, analogues or metabolites thereof | |
| JP2001342132A (ja) | 乳癌を予防し、もしくは治療するための組成物およびそのための方法 | |
| MXPA99009930A (en) | Preparation of isoflavones from legumes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |